Product NDC: | 68308-145 |
Proprietary Name: | Oxycodone Hydrochloride |
Non Proprietary Name: | Oxycodone Hydrochloride |
Active Ingredient(s): | 5 mg/1 & nbsp; Oxycodone Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68308-145 |
Labeler Name: | Midlothian Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA203107 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120731 |
Package NDC: | 68308-145-01 |
Package Description: | 100 CAPSULE in 1 BOTTLE, PLASTIC (68308-145-01) |
NDC Code | 68308-145-01 |
Proprietary Name | Oxycodone Hydrochloride |
Package Description | 100 CAPSULE in 1 BOTTLE, PLASTIC (68308-145-01) |
Product NDC | 68308-145 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Oxycodone Hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20120731 |
Marketing Category Name | ANDA |
Labeler Name | Midlothian Laboratories |
Substance Name | OXYCODONE HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |